Ms Maegon Crader, MA, LPC | |
397 Eagleview Blvd Ste 120, Exton, PA 19341-1150 | |
(610) 422-3064 | |
(484) 870-9846 |
Full Name | Ms Maegon Crader |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 397 Eagleview Blvd Ste 120, Exton, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063779536 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 64435 (Texas) | Secondary |
101YP2500X | Counselor - Professional | PC015868 (Pennsylvania) | Primary |
Entity Name | Twenty-2 Management Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437876448 PECOS PAC ID: 0749648277 Enrollment ID: O20230615001327 |
News Archive
Celsion Corporation announced today that an abstract on its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 2010 Breast Cancer Symposium. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
Temporary combativeness after surgery-a complication affecting up to half of anesthetized children-may be preventable with drugs that decrease epinephrine production, according to a Medical College of Georgia pediatric anesthesiologist.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Maegon Crader, MA, LPC 397 Eagleview Blvd Ste 120, Exton, PA 19341-1150 Ph: (610) 422-3064 | Ms Maegon Crader, MA, LPC 397 Eagleview Blvd Ste 120, Exton, PA 19341-1150 Ph: (610) 422-3064 |
News Archive
Celsion Corporation announced today that an abstract on its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 2010 Breast Cancer Symposium. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
Temporary combativeness after surgery-a complication affecting up to half of anesthetized children-may be preventable with drugs that decrease epinephrine production, according to a Medical College of Georgia pediatric anesthesiologist.
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
› Verified 5 days ago
Stephen Compos Iii, Counselor Medicare: Not Enrolled in Medicare Practice Location: 835 Springdale Dr, Suite 100, Exton, PA 19341 Phone: 610-363-1488 | |
Dr. Eric William Owens, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 91 Dowlin Forge Rd, Exton, PA 19341 Phone: 610-363-7115 | |
Mr. Nathan S Scarbrough, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 390 Waterloo Blvd, Exton, PA 19341 Phone: 262-492-7467 | |
Ashley Marie Adams, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 467 Creamery Way, Exton, PA 19341 Phone: 610-363-1488 | |
Bailey Bain, MSW, LSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 825 Springdale Dr, Exton, PA 19341 Phone: 484-565-1130 | |
Joanne Lewis, CAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 479 Thomas Jones Way, Suite 800, Exton, PA 19341 Phone: 610-648-1130 Fax: 610-560-8219 | |
Nicole Capone, Counselor Medicare: Not Enrolled in Medicare Practice Location: 835 Springdale Dr, Suite 100, Exton, PA 19341 Phone: 610-363-1488 Fax: 610-363-8273 |